Cerca Articoli

Therapeutic antibody MNAC13

Top view of the antigen binding region of the MNAC13 monoclonal antibody: when MNAC13 binds the TrkA receptor, it prevents it from being activated by nerve growth factor.

Patient 'funds stem cell study'

ASTRAZENECA RECEIVES FDA APPROVAL FOR SEROQUEL IN BIPOLAR MANIA

Eli Lilly and Company and Boehringer Ingelheim GmbH: Large-Scale Study in the British Journal of Urology International Shows more than One out of Three Women with Urinary Incontinence (UI) Suffer from Stress Urinary Incontinence (SUI)

Journal also Reports on Duloxetine to Significantly Reduce the Frequency of SUI Episodes and Improve Quality of Life for Women across the Globe

New Viracept 625mg Formulation Will Drastically Reduce Pill Count of One of the Most Widely Used HIV-Drugs

Roche: Viracept Receives Positive Opinion in Europe for New Convenient 625mg Formulation

Schering AG, Germany, Announces European Approval for Radioimmunotherapy Product Zevalin

Chemioterapia immediata efficace per tumore ovarico precoce

ASTRAZENECA SEEKS MANIA INDICATION FOR SEROQUEL-® (QUETIAPINE) IN EUROPE

NEW NEURONS OFFER NEW THERAPIES